🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the effectiveness of a particular...
Status
Completed
Location
The University of Chicago
Start Date
2002-12
Trial ID
NCT00774046
Treatments Being Tested
This is a phase I/II open-label study that is evaluating the toxicity and e...
Status
Terminated
Location
Princess Margaret Hospital
Start Date
2010-10
Trial ID
NCT01222143
Treatments Being Tested
Drugs used in chemotherapy use different ways to stop cancer cells from div...
Status
Completed
Location
Cancer and Leukemia Group B
Start Date
2000-11
Trial ID
NCT00006363
This study examines the use of denileukin diftitox (Ontak) for patients wit...
Status
Terminated
Location
Washington University
Start Date
2008-07-01
Trial ID
NCT00632827
This is a Phase 2, randomized, open-label, multicenter study to evaluate th...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-01-31
Trial ID
NCT04100330
Treatments Being Tested
The purpose of this study is to find out what effects, good and/or bad, the...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge
Start Date
2015-12-14
Trial ID
NCT02633137
Treatments Being Tested
This phase 2, open label, non-randomized study will evaluate the safety of ...
Status
Terminated
Location
University of Florida
Start Date
2022-03-08
Trial ID
NCT04914676
Treatments Being Tested
Rationale:The purpose of this research study is to test the effectiveness o...
Status
Completed
Location
Johns Hopkins School of Medicine The Sidney Kimmel Comprehensive Cancer Center
Start Date
2016-08-22
Trial ID
NCT02768792
Treatments Being Tested
This phase I trial studies the side effects and the best dose of selinexor ...
Status
Completed
Location
University of Chicago Comprehensive Cancer Center
Start Date
2015-10-07
Trial ID
NCT02573363
Treatments Being Tested
This phase I study hopes to explore how safe and tolerable is the combinati...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2019-03-13
Trial ID
NCT03900949